Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Recent & Breaking News (NDAQ:DXR)

Daxor Corporation Announces Hiring of Chief Financial Officer

Marketwired May 31, 2017

Daxor Corporation Announces Delay in Filing of Form N-CSR for December 31, 2016, and the Uniformed Services University of Health Sciences has been awarded a grant to study hemodilution utilizing Daxor's BVA-100 device

Marketwired April 10, 2017

Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor of the Daxor BVA-100 Device, Dr. Joseph Feldschuh

Marketwired February 1, 2017

SCCM17 Randomized Controlled Trial Analysis: Individualized Volume Management Guided by Direct Blood Volume Analysis (BVA) Sharply Lowers Early ICU Mortality vs Pulmonary Artery Catheter Alone

Marketwired January 30, 2017

Daxor Corporation Announces Dividend, Patent Approval, Title Change

Marketwired November 18, 2016

Daxor Corp. Reports Presentation of Two New Studies at Heart Failure Society of America Meeting

Benzinga.com  September 29, 2016

Daxor Corporation Announces Two New Studies From the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients

Marketwired September 29, 2016

Daxor Corporation Announces Filing of Form N-CSR for June 30, 2016

Marketwired September 15, 2016

In Heart Failure, One Size Does Not Fit All: New Mayo Clinic BVA Study Published in Journal of the American College of Cardiology-Heart Failure Highlights the Need for Individualized Decongestive Strategies

Marketwired July 27, 2016

Daxor Corporation Announces Hiring of Chief Financial Officer

Marketwired June 17, 2016

Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood Volume Analysis: New Data Presented at the American College of Cardiology Congress

Marketwired April 6, 2016

University of Hawaii and The Queen's Medical Center Reports on a Study on Critically Ill Patients Utilizing Blood Volume Measurement and Pulmonary Artery Catheterization

Marketwired March 9, 2016

Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent Developments

Marketwired February 29, 2016

Daxor Corporation Announces Return of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery

Press Releases February 17, 2016

Daxor Corporation Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine

Marketwired February 8, 2016

Technical Data Drives the Market - Analyst Review of Orkla, Magic Software Enterprises, Iao Kun Group Holding, and Daxor

Accesswire January 29, 2016

Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis

Marketwired December 10, 2015

Daxor Corporation Announces Filing of Form N-Q for September 30, 2015

Marketwired November 27, 2015

Second Heart Failure Study From the Mayo Clinic Utilizing Daxor's BVA-100 Blood Volume Analyzer Published in Journal of Cardiovascular Trans. Res. (2015) 8:404-410

Marketwired November 25, 2015

Heart Failure Research From the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer Presented at the Annual Heart Failure Society of America Meeting

Marketwired October 1, 2015